A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Daunorubicin hydrochloride EP Impurity E | Daunorubicin EP Impurity E is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: Daunorubicin Impurity E; (8S,10S)-6,8,10,11-Tetrahydroxy-8-[(1RS)-1-hydroxyethyl]-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; Daunorubicinol aglycone (Mixture of Diastereomers); Dihydrodaunomycinone (Mixture of Diastereomers); (8S,10S)-7,8,9,10-Tetrahydro-6,8,10,11-tetrahydroxy-8-(1-hydroxyethyl)-1-methoxy-5,12-naphthacenedione; 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(1-hydroxyethyl)-1-methoxy-, (8S,10S)-; Daunorubicin EP Impurity E; Daunorubicin hydrochloride Impurity E. Grade: ≥95%. Molecular formula: C21H20O8. Mole weight: 400.38. |  |
| Daunorubicin hydrochloride impurity 1 | Daunorubicin hydrochloride impurity 1. Uses: For analytical and research use. CAS No. 126643-96-7. Molecular formula: C27H31NO10. Mole weight: 529.54. Catalog: APB126643967. |  |
| Daunorubicin hydrochloride impurity 2 | Daunorubicin hydrochloride impurity 2. Uses: For analytical and research use. CAS No. 28008-55-1. Molecular formula: C27H31NO10. Mole weight: 529.54. Catalog: APB28008551. | |
| Daunorubicin hydrochloride impurity 3 | Daunorubicin hydrochloride impurity 3. Uses: For analytical and research use. Molecular formula: C27H31NO10. Mole weight: 529.54. Catalog: APB11036. | |
| Daunorubicin hydrochloride impurity 6 | Daunorubicin hydrochloride impurity 6. Uses: For analytical and research use. CAS No. 28008-51-7. Molecular formula: C21H20O8. Mole weight: 400.38. Catalog: APB28008517. | |
| Daunorubicin hydrochloride impurity 7 | Daunorubicin hydrochloride impurity 7. Uses: For analytical and research use. CAS No. 125515-17-5. Molecular formula: C21H20O8. Mole weight: 400.38. Catalog: APB125515175. | |
| Daunorubicin hydrochloride impurity 8 | Daunorubicin hydrochloride impurity 8. Uses: For analytical and research use. CAS No. 2747975-46-6. Molecular formula: C21H20O8. Mole weight: 400.38. Catalog: APB2747975466. | |
| Daunorubicin Hydrochloride (Mixture of Diastereomers) | Daunorubicin Hydrochloride (Mixture of Diastereomers). Group: Biochemicals. Alternative Names: (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride; (8S-cis)-Daunomycin Hydrochloride; Cerubidine; Daunoblastin; Daunomycin Chlorohydrate; ?NDC 0082-4155; Ondena; RP 13057 Hydrochloride; Rubidomycin Hydrochloride. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. |  Worldwide |
| Daunorubicin Impurity 1 | Daunorubicin Impurity 1 is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 2,3,6-trideoxy-3-(trifluoroacetamido)-alpha-L-lyxo-hexopyranose; 2,3,6-trideoxy-3-(trifluoroacetamido)-L-lyxo-hexose; N-trifluoroacetyl-α,β-daunosamine; N-trifluoroacetyl-L-daunosamide; N-(trifluoroacetyl)daunosamine. CAS No. 51996-45-3. Molecular formula: C8H12F3NO4. Mole weight: 243.18. | |
| Daunorubicin impurity 12 | Daunorubicin impurity 12. Uses: For analytical and research use. CAS No. 76034-18-9. Molecular formula: C26H29NO9. Mole weight: 499.52. Catalog: APB76034189. | |
| Daunorubicin impurity 13 | Daunorubicin impurity 13. Uses: For analytical and research use. CAS No. 100992-86-7. Molecular formula: C21H20O7. Mole weight: 384.38. Catalog: APB100992867. | |
| Daunorubicin Impurity 13 | Daunorubicin Impurity 13. Uses: For analytical and research use. Alternative Names: N-((2S,3S,4S,6R)-3,6-dihydroxy-2-methyltetrahydro-2H-pyran-4-yl)-2,2,2-trifluoroacetamide. CAS No. 51996-45-3. Molecular formula: C8H12F3NO4. Mole weight: 243.18. Catalog: APB51996453. | |
| Daunorubicin Impurity 14 | Daunorubicin Impurity 14. Uses: For analytical and research use. Alternative Names: (2S,4S,5S,6S)-6-methyl-4-(2,2,2-trifluoroacetamido)tetrahydro-2H-pyran-2,5-diyl bis(4-nitrobenzoate). Molecular formula: C22H18F3N3O10. Mole weight: 541.39. Catalog: APB05531. | |
| Daunorubicin Impurity 17 | Daunorubicin Impurity 17. Uses: For analytical and research use. Alternative Names: 8-acetyl-6,11-dihydroxy-1-methoxytetracene-5,12-dione. CAS No. 32434-04-1. Molecular formula: C21H14O6. Mole weight: 362.33. Catalog: APB32434041. | |
| Daunorubicin Impurity 18 | Daunorubicin Impurity 18. Uses: For analytical and research use. Alternative Names: 8-acetyl-6,10,11-trihydroxy-1-methoxytetracene-5,12-dione. CAS No. 20982-41-6. Molecular formula: C21H14O7. Mole weight: 378.33. Catalog: APB20982416. | |
| Daunorubicin Impurity 19 | Daunorubicin Impurity 19. Uses: For analytical and research use. Alternative Names: (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-bromo-1,1-diethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione. Molecular formula: C31H38BrNO11. Mole weight: 680.54. Catalog: APB05529. | |
| Daunorubicin Impurity 2 | Daunorubicin Impurity 2 is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 2,3,6-Trideoxy-1,4-bis-O-(4-nitrobenzoyl)-3-[(trifluoroacetyl)amino]-α-L-lyxo-hexopyranose; α-L-lyxo-Hexopyranose, 2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-, 1,4-bis(4-nitrobenzoate); (2S,4S,5S,6S)-6-methyl-4-(2,2,2-trifluoroacetamido)tetrahydro-2H-pyran-2,5-diyl bis(4-nitrobenzoate); α-L-lyxo-Hexopyranose, 2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-, 1,4-bis(4-nitrobenzoate). CAS No. 63700-24-3. Molecular formula: C22H18F3N3O10. Mole weight: 541.39. | |
| Daunorubicin Impurity 20 | Daunorubicin Impurity 20. Uses: For analytical and research use. Alternative Names: (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-(benzyloxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione. CAS No. 1010447-40-1. Molecular formula: C34H35NO10. Mole weight: 617.64. Catalog: APB1010447401. | |
| Daunorubicin Impurity 21 | Daunorubicin Impurity 21. Uses: For analytical and research use. Alternative Names: (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-(benzyloxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione. CAS No. 677017-23-1. Molecular formula: C34H35NO11. Mole weight: 633.64. Catalog: APB677017231. | |
| Daunorubicin Impurity 24 HCl | Daunorubicin Impurity 24 HCl. Uses: For analytical and research use. Alternative Names: (8S,10S)-8-acetyl-10-(((2R,4S)-4-amino-6-methyl-3,4-dihydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride. Molecular formula: C27H27NO9·HCl. Mole weight: 545.98. Catalog: APB05528. | |
| Daunorubicin Impurity 3 Dihydrochloride | Daunorubicin Impurity 3 Dihydrochloride is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: Daunorubicin Impurity 3 DiHCl; 5,12-Naphthacenedione, 9-acetyl-7,9-bis[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-, dihydrochloride, (7S-cis)-. CAS No. 99457-12-2. Molecular formula: C32H38N2O11.2HCl. Mole weight: 699.57. | |
| Daunorubicin impurity 6 | Daunorubicin impurity 6. Uses: For analytical and research use. Alternative Names: 56390-08-0 (HCl Salt); (8S,10S)-8-acetyl-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione. CAS No. 57918-24-8. Molecular formula: C27H29NO10. Mole weight: 527.52. Catalog: APB57918248. | |
| Daunorubicin Impurity 7 | Daunorubicin Impurity 7 is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-(2-bromo-1,1-diethoxyethyl)-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; Doxorubicin Impurity 15; (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-. CAS No. 131086-18-5. Molecular formula: C31H38BrNO11. Mole weight: 680.55. | |
| Daunorubicin Impurity 8 | Daunorubicin Impurity 8 is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-(benzyloxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; (8S,10S)-8-Acetyl-10-[[3-amino-2,3,6-trideoxy-4-O-(phenylmethyl)-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione. Grade: ≥95%. CAS No. 1010447-40-1. Molecular formula: C34H35NO10. Mole weight: 617.65. | |
| Daunorubicin impurity 9 | Daunorubicin impurity 9. Uses: For analytical and research use. Molecular formula: C27H32ClNO11. Mole weight: 582. Catalog: APB11037. | |
| Daunorubicin Impurity C (Mixture of Diastereomers) | Daunorubicin Impurity C (Mixture of Diastereomers). Uses: For analytical and research use. Alternative Names: (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-8-(2-oxopropyl)-7,8,9,10-tetrahydrotetracene-5,12-dione. CAS No. 79438-97-4. Molecular formula: C28H31NO10. Mole weight: 541.55. Catalog: APB79438974. | |
| Daunorubicinol | Daunorubicinol, a metabolite of Daunorubicin, is an anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin. Synonyms: Daunorubicin Impurity B ((1S)-isomer); 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-((1S)-1-hydroxyethyl)-1-methoxy-, (8S,10S)-; 13-Dihydrodaunorubicin; Duborimycin; Leukaemomycin D; (13S)-13-Dihydrodaunorubicin; (1S,3S)-3,5,12-Trihydroxy-3-[(1S)-1-hydroxyethyl]-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl-3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside; Daunomycinol; Dihydrodaunomycin; Antibiotic 20-798RP; 13-Dihydrodaunomycin. Grade: >95%. CAS No. 28008-55-1. Molecular formula: C27H31NO10. Mole weight: 529.54. | |
| Daunorubicinol-[d3] | Daunorubicinol-[d3]. Synonyms: Daunorubicinol-d3. Molecular formula: C27H28D3NO10. | |
| Daunorubicinol formate salt (mixture of diastereoisomers) | Daunorubicinol formate salt (mixture of diastereoisomers) is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-((S)-1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione formate; 13-Dihydrodaunorubicin formate; Duborimycin formate; Leukaemomycin D formate; (1S,3S)-3,5,12-Trihydroxy-3-[(1R)-1-hydroxyethyl]-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside formate (1:1); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-[(1R)-1-hydroxyethyl]-1-methoxy-, (8S,10S)-, formate (1:1). Grade: 95%. Molecular formula: C28H33NO12. Mole weight: 575.57. | |
| Daunorubicinol hydrochloride | Daunorubicinol Hydrochloride is a metabolite of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, hydrochloride, [8S-[8α,8(R*),10α]]-; 13-Dihydrodaunorubicin Hydrochloride; Duborimycin Hydrochloride; Leukaemomycin D Hydrochloride; L-lyxo-Hexopyranoside, 1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-, hydrochloride, (1S,3S)-α-; 13-Dihydrodaunomycin hydrochloride; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-[(1S)-1-hydroxyethyl]-1-methoxy-, hydrochloride (1:1), (8S,10S)-; Antibiotic RP 20798; Antibiotic 20798 RP; Dihydrodaunomycin hydrochloride; NSC 180510. Grade: ≥95%. CAS No. 28008-53-9. Molecular formula: C27H32ClNO10. Mole weight: 566.00. | |
| Daunorubicinol TFA | Daunorubicinol TFA is a metabolite of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, trifluoroacetic acid, [8S-[8α,8(R*),10α]]-; 13-Dihydrodaunorubicin trifluoroacetic acid; Duborimycin trifluoroacetic acid; Leukaemomycin D trifluoroacetic acid; 13-Dihydrodaunomycin trifluoroacetic acid; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-[(1S)-1-hydroxyethyl]-1-methoxy-, trifluoroacetic acid (1:1), (8S,10S)-. Molecular formula: C27H31NO10.C2HF3O2. Mole weight: 643.57. | |
| dAurAB5 | dAurAB5 is a dual Aurora-A (DC50 = 8.8 nM) and Aurora-B (DC50 = 6.1 nM) PROTAC degrader. dAurAB5 induces degradation of Aurora-A and Aurora-B, reduces N-Myc levels, and decreases viability in IMR32 neuroblastoma cells. dAurAB5 downregulates the levels of AAK1, PTK2, GAK, and TTK. dAurAB5 can be used to study cancers such as neuroblastoma. (Pink: TTK ligand 2: HY-168542, Blue: Thalidomide-O-COOH: HY-103597, Black: 6-Aminocaproic acid: HY-B0236)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3115765-45-9. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-171770. |  |
| Daurichromenic acid | Daurichromenic acid, isolated from the herbs of Rhododendron dauricum, is a terpenophenol with potent anti-HIV activity. Uses: Anti-hiv activity. Synonyms: Daurichromenic acid; 82003-90-5; (S,E)-2-(4,8-Dimethylnona-3,7-dien-1-yl)-5-hydroxy-2,7-dimethyl-2H-chromene-6-carboxylic acid; (+)-Daurichromenic acid; Dauichromenic acid; (+)-Daurichromenic acid; CHEMBL1171643; HY-N3692; BDBM50537945; AKOS040761576; FS-9068; (2S)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-5-hydroxy-2,7-dimethylchromene-6-carboxylic acid; DA-72571; CS-0024072; (2S)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-5-hydroxy-2,7-dimethyl-chromene-6-carboxylic acid; (S)-2-((E)-4,8-Dimethyl-nona-3,7-dienyl)-5-hydroxy-2,7-dimethyl-2H-1-benzopyran-6-carboxylic acid. Grade: 97%. CAS No. 82003-90-5. Molecular formula: C64H78N14O24. Mole weight: 1427.4. | |
| Dauricine | Dauricine. Group: Biochemicals. Alternative Names: 6,6?-Di-O-methyldauricoline. Grades: Plant Grade. CAS No. 524-17-4. Pack Sizes: 20mg. Molecular Formula: C38H44N2O6, Molecular Weight: 624.766. US Biological Life Sciences. | Worldwide |
| DAURICINE | Dauricine had a good inhibition effect on tumor cells in urinary system. At the same time, Dauricine has certain inhibition effects on the primary cultured tumor cell. Uses: Antiarrhythmic. Synonyms: 4-[[(1R)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]phenol; 4-[((1R)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methylisoquinolin-1-yl)methyl]-2-[4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinolin-1-yl]methyl]phenoxy]phenol; Dauricine; dauricine (8ci); Menispermum dauricum DC Extract; 6,6'-Di-O-Methyldauricoline. Grade: >98%. CAS No. 524-17-4. Molecular formula: C38H44N2O6. Mole weight: 624.77. | |
| Dauricinoline | Dauricinoline. Group: Biochemicals. Grades: Plant Grade. CAS No. 30984-80-6. Pack Sizes: 10mg. Molecular Formula: C37H42N2O6, Molecular Weight: 610.74. US Biological Life Sciences. | Worldwide |
| Daurinoline | Daurinoline. Group: Biochemicals. Grades: Plant Grade. CAS No. 2831-75-6. Pack Sizes: 10mg. Molecular Formula: C37H42N2O6, Molecular Weight: 610.74. US Biological Life Sciences. | Worldwide |
| Daurisoline | Daurisoline. Group: Biochemicals. Grades: Plant Grade. CAS No. 70553-76-3. Pack Sizes: 20mg. Molecular Formula: C37H42N2O6, Molecular Weight: 610.74. US Biological Life Sciences. | Worldwide |
| Davalintide | Davalintide is an Amylin (HY-P1464)-mimetic peptide with greater potency and longer-lasting effects. Davalintide is a potent agonist of amylin receptor (IC50 = 0.04 nM), calcitonin receptor (IC50 = 0.06 nM) and calcitonin related peptide receptor (CGRP receptor) (IC50 = 3.1 nM). Davalintide shows stronger potency to Amylin to activate cyclic AMP production through the calcitonin receptor (EC50 = 1.4 nM). Davalintide regulates blood sugar and weight through various mechanisms such as delaying gastric emptying, inhibiting glucagon secretion, and reducing food intake. Davalintide can be used for the studies of anti-obesity and anti-diabetes[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 863919-85-1. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-P11320. | |
| Davana oil | Davana oil. Alternative Names: Artemisia pallens herb oil. CAS No. 8016-3-3. Purity: 99%. Product ID: FFC8016033. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| Davana Oil | Davana Oil. CAS No. 8016-03-3. FEMA No. 2359. Kosher: Y. VIGON Item # 500105. Categories: Speciality Ingrdients Suppliers, Flavors, Fragrances, Perfumers. |  America & Internationally |
| Davercin | Erythromycin Cyclocarbonate, a derivative of Erythromycin, inhibits protein synthesis of bacteria by binding to the 50S ribosome. Synonyms: Erythromycin A 11,12-carbonate; Erythromycin A cyclic 11,12-carbonate; Erythromycin cyclic carbonate. Grade: >98%. CAS No. 55224-05-0. Molecular formula: C38H65NO14. Mole weight: 759.92. | |
| Davidigenin | Davidigenin is an antidiabetic compound with antitumor, antispasmodic, and antioxidant activities. Davidigenin inhibits duodenal contractions induced by acetylcholine or histamine. Uses: Scientific research. Category: Signaling pathways. CAS No. 23130-26-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-W983015. | |
| Davis oxaziridine | Davis oxaziridine. Group: Biochemicals. Alternative Names: 2-(Phenylsulfonyl)-3-phenyloxaziridine; 2-(Benzenesulfonyl)-3-phenyloxaziridine; 3-Phenyl-2-(phenylsulfonyl)-1,2-oxaziridine. Grades: Highly Purified. CAS No. 63160-13-4. Pack Sizes: 1g, 2g, 5g, 10g, 25g. Molecular Formula: C13H11NO3S. US Biological Life Sciences. | Worldwide |
| Davutamig | Davutamig (REGN-5093) is a human IgG4-kappa, anti-MET bispecific antibody. Davutamig binds 2 distinct epitopes of MET, blocking ligand binding and inducing MET internalization and degradation. Davutamig is applicable to the research of advanced non-small cell lung cancer with MET gene abnormalities[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: REGN-5093. CAS No. 2648058-48-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990073. | |
| Daxdilimab | Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MEDI7734; VIB7734. CAS No. 2245966-28-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99226. | |
| Daxdilimab | Daxdilimab is a human anti-ILT7 monoclonal antibody. Daxdilimab binds to ILT7 on the surface of pDCs, which leads to the depletion of these cells and inhibits inflammation in a variety of autoimmune conditions. Synonyms: MEDI7734; VIB7734; HZN-7734. CAS No. 2245966-28-1. | |
| Daylily Extract 4:1 | Daylily Extract 4:1. |  CA, FL & NJ |
| DAz-2 | DAz-2 is a sulfonic acid probe for living cells, which can directly detect sulfonic acid-modified proteins in living cells and is cell-permeable[1]. Uses: Scientific research. Category: Fluorescent dyes. CAS No. 1176905-54-6. Pack Sizes: 5 mg; 10 mg. Product ID: HY-132278. | |
| D-Azetidine-2-Carboxylic Acid | A four-membered ring analog of L-Proline. A useful intermediate in the synthesis of polypeptides. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 500mg. US Biological Life Sciences. | Worldwide |
| Dazodalibep | Dazodalibep (MEDI 4920; VIB 4920) is a non-antibody fusion protein that targets CD40L. Dazodalibep inhibits the co-stimulatory signals between immune cells (such as T cells, B cells, and antigen-presenting cells), thereby enabling the inhibition of a broader range of cellular and humoral responses. Dazodalibep can be used for research on rheumatoid arthritis and Sjögren's syndrome[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MEDI 4920; VIB 4920. CAS No. 2245953-10-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99845. | |
| Dazomet | Dazomet. Group: Biochemicals. Alternative Names: Di methyl formocarbothialdine; Fennosan B 100; Metasol D 3TA; Mylone; Mylone 85; N 521; NSC 4737; Nalco 5787; Nalcon 243; Nefusan; Nuosept S; Stauffer N 521; Tetrahydro-2H-3,5-dimethyl-1,3,5-thiadiazine-2-thione; Tetrahydro-3,5-dimethyl-1,3,5-thiadiazin-2-thione; Tetrahydro-3,5-dimethyl-2H-1,3,5-thiadiazine-2-thione; Tetrahydro-3,5-dimethyl-2H-1,3,5-thiodiazin-2-thione; Thiazon; Thiazone; UCC 974; 2-Thio-3,5-dimethyltetrahydro-1,3,5-thiadiazine; 3,5-Dimethyl-2-thionotetrahydro-1,3,5-thiadiazine; 3,5-Dimethyltetrahydro-1,3,5-2H-thiadiazine-2-thione; 3,5-Dimethyltetrahydro-1,3,5-thiadiazine-2-thione; 3,5-Dimethyltetrahydro-2H-1,3,5-thiadiazine-2-thione; AMA 424; Basamid; Basamid G; Basamid P; Basamid-Puder; Busan; Busan 1058; Crag 85W; Crag 974; D 35; DMTT. Grades: Highly Purified. CAS No. 533-74-4. Pack Sizes: 1g. Molecular Formula: C5H10N2S2, Molecular Weight: 162.28. US Biological Life Sciences. | Worldwide |
| Dazonone | Dazonone is a specific PDE III inhibitor. Synonyms: 6-Chloro-3-methyl-3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one. Grade: 95%. CAS No. 105622-85-3. Molecular formula: C11H10ClN3O. Mole weight: 235.67. | |
| Dazostinag disodium | Dazostinag disodium (TAK-676) is an agonist of STING, triggering the activation of STING signaling pathway and type I interferons. Dazostinag disodium is also a modulator of immune system, resulting complete regressions and durable memory T-cell immunity. Dazostinag disodium promotes durable IFN-dependent antitumor immunity[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: TAK-676. CAS No. 2553413-93-5. Pack Sizes: 10 mM * 1 mL in Water; 100 μg; 500 μg; 1 mg; 5 mg; 10 mg. Product ID: HY-148029. | |
| Dazoxiben | Dazoxiben is a potent, selevtive and orally active inhibitor of thromboxane (TX) synthase, which has potential effects in patients with Raynaud's syndrome. Synonyms: Dazoxiben free base. Grade: 98%. CAS No. 78218-09-4. Molecular formula: C12H12N2O3. Mole weight: 232.24. | |
| Dazoxiben | Dazoxiben. Group: Biochemicals. Grades: Highly Purified. CAS No. 78218-09-4. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. US Biological Life Sciences. | Worldwide |
| Dazoxiben hydrochloride | Dazoxiben is a potent, selevtive and orally active inhibitor of thromboxane (TX) synthase, which has potential effects in patients with Raynaud's syndrome. Synonyms: Dazoxiben HCl. CAS No. 74226-22-5. Molecular formula: C12H13ClN2O3. Mole weight: 268.69. | |
| Dazoxiben hydrochloride | Dazoxiben hydrochloride is a potent and orally active thromboxane (TX) synthase inhibitor[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: UK 37248. CAS No. 74226-22-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-106067A. | |
| Dazucorilant | Dazucorilant is a glucocorticoid receptor antagonist. Synonyms: {(4aR)-1-(4-fluorophenyl)-6-[4-(trifluoromethyl)benzene-1-sulfonyl]-1,4,5,6,7,8-hexahydro-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl}(pyridin-2-yl)methanone; (R)-(1-(4-fluorophenyl)-6-((4-(trifluoromethyl)phenyl)sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl)(pyridin-2-yl)methanone. CAS No. 1496508-34-9. Molecular formula: C29H22F4N4O3S. Mole weight: 582.58. | |
| Dazucorilant | Dazucorilant (CORT113176) is a selective and high affinity non-steroidal glucocorticoid receptor (GR) modulator with a Ki value ?1 nM in vitro. Dazucorilant can be used for the research of neurological disorders[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: CORT113176. CAS No. 1496508-34-9. Pack Sizes: 5 mg; 10 mg; 25 mg. Product ID: HY-132811. | |
| Dazukibart | Dazukibart (PF-06823859) is a potent, selective humanized IgG1 neutralizing monoclonal antibody that targets interferon β (IFNβ). Dazukibart can be used in the study of moderate to severe dermatomyositis[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PF-06823859. CAS No. 2639474-65-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990036. | |
| Dazzling Cellular Silver Warrior | Dazzling Cellular Silver Warrior. Product ID: CDC10-0707. Category: Cosmetic Packaging Material. Product Keywords: Cosmetic Ingredients; Mask; CDC10-0707; Dazzling Cellular Silver Warrior; Cosmetic Packaging Material;. |  |
| DB008 | DB008 is potent and selective PARP16 inhibitor with an IC50 value of 0.27 μM, containing an acrylamide electrophilic reagent. DB008 is membrane-permeable and marks PARP16 selectively[1]. DB008 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. Uses: Scientific research. Category: Signaling pathways. CAS No. 2991637-98-8. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-150221. | |
| DB04760 | DB04760 (compound 4) is a potent, highly selective, non-zinc-chelating MMP-13 inhibitor with an IC50 of 8 nM[1]. DB04760 significantly reduces paclitaxel neurotoxicity and has anticancer activity[2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 544678-85-5. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 50 mg. Product ID: HY-125166. | |
| DB0614 | DB0614 is a PROTAC based on Cereblon ligand, which is a selective and potent targeted protein degrader of NEK9 inhibitor. DB0614 can degrade ABL1, ABL2, BLK, CDK11B, CDK4, CSK, EPHA3, FER, GAK, LIMK1, MAP3K20, MAP4K1, MAP4K2, MAP4K3, MAP4K5, MAPK14, MAPK7, MAPK8, MAPK9, MAPKAPK2, MAPKAPK3, NLK, PDIK1L, PTK2B, RIPK1, RPS6KA1, RPS6KA3, SIK2, SIK3, STK35, TNK2 and ULK1. DB0614 can be used for research of disease or disorder mediated by aberrant kinase activity[1][2].(Blue: Thalidomide-4-OH (HY-103596), Black: linker, Pink: FLT3-IN-17 (HY-148070)). Uses: Scientific research. Category: Signaling pathways. CAS No. 2769753-47-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-148063. | |
| DB07268 | DB07268 is a potent and selective JNK1 inhibitor with an IC50 value of 9 nM. Uses: Scientific research. Category: Signaling pathways. CAS No. 929007-72-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-15737. | |
| DB07268 | DB07268 is a potent and selective JNK1 inhibitor. It has some degree of selectivity over quite a few kinases with the exceptions of CHK1, CK2, and PLK. Synonyms: DB07268; DB-07268; DB 07268. Grade: >98%. CAS No. 929007-72-7. Molecular formula: C17H15N5O2. Mole weight: 321.33. | |
| DB1113 | DB1113 (Example 24) is a bifunctional compound targeted protein degradation of kinases. DB1113 degrades ABL1, ABL2, BLK, CDK11B, CDK4, CSK, EPHA3, FER, GAK, LIMK1, MAP3K20, MAP4K1, MAP4K2, MAP4K3, MAP4K5, MAPK14, MAPK7, MAPK8, MAPK9, MAPKAPK2, MAPKAPK3, NLK, PDIK1L, PTK2B, RIPK1, RPS6KA1, RPS6KA3, SIK2, SIK3, STK35, TNK2, and ULK1. DB1113 can be used for research of disease or disorder mediated by aberrant kinase activity[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2769753-53-7. Pack Sizes: 5 mg; 10 mg. Product ID: HY-148061. | |
| DB18 | DB18 is a potent and selective inhibitor of CDC2-like kinases (CLKs), with IC50 values in the range of 10-30 nM for CLK1, CLK2 and CLK4. DB18 has anti-tumor activity[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2587177-94-2. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-131978. | |
| DB1976 | DB1976 is a selenophene analog of DB270 and a potent and cell-permeable fully efficacious transcription factor PU.1 inhibitor. It potently inhibits PU.1 binding and strongly inhibits the PU.1/DNA complex in vitro. DB1976 has apoptosis-inducing effect. Synonyms: 2,2'-(Selenophene-2,5-diyl)bis(1H-benzo[d]imidazole-6-carboximidamide); DB-1976; DB-1976. CAS No. 1557397-51-9. Molecular formula: C20H16N8Se. Mole weight: 447.35. | |
Our database is helping our users find suppliers everyday.
